PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION OF MEGAKARYOCYTOPOIESIS IN NORMAL HUMAN BONE-MARROW AND REACTIVE LESIONS WITH SPECIAL EMPHASIS ON HIV-MYELOPATHY

被引:3
|
作者
THIELE, J
TITIUS, BR
KVASNICKA, HM
BERTSCH, HP
ERDMANN, S
FISCHER, R
机构
[1] Institute of Pathology, University of Cologne
关键词
MEGAKARYOCYTOPOIESIS; ENDOREDUPLICATION; PCNA-EXPRESSION; HIV-MYELOPATHY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; REACTIVE THROMBOCYTOSIS; DOUBLE-IMMUNOSTAINING; BONE MARROW TREPHINES;
D O I
10.1016/S0344-0338(11)80495-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A morphometric analysis was performed on bone marrow trephine biopsies using sequential double-immunostaining, to evaluate endoreduplicative activity of megakaryocytopoiesis. A total of 104 marrow specimens were studied with employment of monoclonal antibodies PC10 (anti-proliferating cell nuclear antigen - PCNA) and Y2/51-CD61 (anti-platelet glycoprotein IIIa). In addition to the control group patients included non-specific inflammatory changes, HIV-myelopathy with normal or decreased platelet counts, idiopathic thrombocytopenic purpura (ITP), and finally reactive thrombocytosis (TH). To exclude an undue overexpression of PCNA, in a comparative pilot study we also applied MIB1 (Ki-67 antigen) on normal bone marrow specimens. In accordance with the various modalities of cell-cycle marker expression, no significantly different findings were disclosed. PCNA-labelling index was relatively low, ranging from 0.8 to 1.7% of the total megakaryocytopoiesis (promegakaryoblasts to mature platelet-shedding megakaryocytes). A significant relationship between megakaryocyte size and PCNA-expression was determinable. This implies that some of the cases with a prevalence of small megakaryocytes, like ITP, have the tendency to show a higher proportion of positively-stained cells. Moreover, this feature confirms a hypothesis postulating a decrease in the time for DNA-synthesis (S-phase) and a relative prolongation of the G1/G2-phases of the cell-cycle at higher ploidy levels (large-sized megakaryocytes). On the other hand, it may be speculated that some of the hyperpolyploid giant megakaryocytes may have reached their endstage of endoreduplication and enter into G0-phase. In comparison with the control group and the other entities under study, a significant reduction of PCNA-reactivity was recognizable in HIV-myelopathy accompanied by thrombocytopenia. Our findings are in keeping with cell culture studies assuming that, opposed to ITP and TH, in AIDS different kinetic properties of the megakaryocytic lineage have to be encountered. In this context, it may not entirely be ruled out that viral infection has an inhibitory effect on the stability of mRNA for PCNA and therefore could cause an undue reduction of PCNA-immunostaining.
引用
收藏
页码:42 / 50
页数:9
相关论文
共 33 条
  • [1] PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION BY ERYTHROID PRECURSORS IN NORMAL BONE-MARROW, IN REACTIVE LESIONS AND IN POLYCYTHEMIA-RUBRA-VERA
    THIELE, J
    MEUTER, RB
    TITIUS, RB
    ZANKOVICH, R
    FISCHER, R
    HISTOPATHOLOGY, 1993, 22 (05) : 429 - 435
  • [2] AIDS-related bone marrow lesions - Myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling
    Thiele, J
    Zirbes, TK
    Bertsch, HP
    Titius, BR
    Lorenzen, J
    Fischer, R
    ANALYTICAL CELLULAR PATHOLOGY, 1996, 11 (03) : 141 - 157
  • [3] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA/CYCLIN) EXPRESSION IN MELANOCYTIC LESIONS OF SKIN
    AHMED, I
    MULLER, SA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 546 - 546
  • [4] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA CYCLIN) EXPRESSION IN MELANOCYTIC LESIONS OF SKIN
    AHMED, I
    MULLER, SA
    CLINICAL RESEARCH, 1993, 41 (02): : A426 - A426
  • [5] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN HUMAN GLIOMAS AND MENINGIOMAS
    BURNS, DK
    MICKEY, BE
    BIGIO, EH
    WHITE, CL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (03): : 362 - 362
  • [6] EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN HUMAN PARATHYROID ADENOMA
    KURIMOTO, S
    MORIYAMA, N
    NAGASE, Y
    DOI, N
    ASO, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1993, 26 (05) : 391 - 396
  • [7] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) - EXPRESSION IN SAMPLES OF HUMAN ASTROCYTIC GLIOMAS
    REVESZ, T
    ALSANJARI, N
    DARLING, JL
    SCARAVILLI, F
    LANE, DP
    THOMAS, DGT
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1993, 19 (02) : 152 - 158
  • [8] IMAGE-ANALYSIS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN BREAST-LESIONS
    BUR, M
    SHIRAKI, W
    LABORATORY INVESTIGATION, 1993, 68 (01) : A12 - A12
  • [9] ELEVATED EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN NONCYCLING IMMATURE HUMAN THYMOCYTES
    HANASH, S
    GRATIOTDEANS, J
    KEIM, D
    STRAHLER, J
    TURKA, L
    FASEB JOURNAL, 1992, 6 (05): : A1696 - A1696
  • [10] Proliferating cell nuclear antigen (PCNA) expression in bone marrow biopsies and its prognostic importance in chronic lymphocytic leukemia (CLL).
    Cliquet, MG
    Alves, VA
    Nonogaki, S
    Menezes, Y
    Dorlhiac-Llacer, PE
    BLOOD, 1999, 94 (10) : 296B - 296B